Iterum Therapeutics reported cash from operations of -$7.45M and free cash flow of -$7.46M for the quarter ended Sep 2025, down 178.7% year over year. This cash flow statement covers 34 quarters of results from Jun 2017 through Sep 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||
| Net Income | -4.73M | -98.92M | 7.80M | 3.74M | 7.88M | -3.50M | -6.74M | -29.11M | 0.73M | -9.89M | -12.24M | -3.88M | -8.77M | -7.10M | -5.00M | -6.09M | -3.65M | -4.89M | -6.51M | -8.98M | ||||||||||||||
| Share-based Compensation | 0.13M | 0.69M | 25.70M | 23.85M | 1.97M | 16.23M | 19.58M | 1.81M | 0.46M | 1.21M | 1.40M | 1.25M | 0.14M | 1.11M | 0.99M | 0.91M | 0.09M | 0.83M | 0.76M | 0.94M | ||||||||||||||
| Cash from Operations | -9.03M | -1.13M | -8.34M | -3.91M | -2.46M | -3.40M | -6.26M | -4.54M | -4.26M | -9.59M | -7.63M | -9.27M | -12.84M | -13.08M | -6.76M | -2.67M | -4.26M | -3.06M | -4.75M | -7.45M | ||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||
| Amortization of Deferred Charges | 3.11M | 2.37M | 0.60M | 0.59M | 0.46M | 0.57M | 0.58M | 0.59M | 0.59M | 0.58M | 0.58M | 0.59M | 0.59M | 0.57M | 0.57M | 0.57M | 0.57M | 0.19M | ||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||
| Change in Inventory | 0.53M | 0.41M | 0.20M | |||||||||||||||||||||||||||||||
| Change in Account Payables | -1.79M | 1.04M | 0.09M | -1.67M | 0.60M | -0.20M | 0.10M | 0.44M | 1.54M | -0.54M | 1.48M | 1.80M | -0.52M | -2.03M | -2.14M | 0.01M | -0.58M | 0.16M | 0.78M | -0.61M | ||||||||||||||
| Change in Accured Expenses | -0.40M | -0.27M | -0.29M | -0.13M | -0.42M | 0.81M | 0.99M | 0.78M | 0.61M | -0.75M | 1.56M | 3.97M | -1.29M | -5.90M | 0.40M | 1.23M | -0.84M | 0.23M | 1.07M | 1.34M | ||||||||||||||
| Change in Taxes | -0.03M | 0.06M | -0.20M | -0.26M | 0.67M | 0.43M | -0.56M | -0.49M | 0.11M | 0.11M | 0.19M | 0.05M | -0.08M | 0.05M | -0.19M | 0.14M | 0.16M | 0.06M | -0.01M | -0.09M | ||||||||||||||
| Other Working Capital Changes | 1.92M | -3.17M | 1.03M | 0.62M | 0.51M | -0.18M | 1.55M | 0.38M | -0.19M | 1.45M | 1.28M | -0.17M | 0.63M | -0.23M | 1.45M | 1.35M | 0.09M | 0.13M | 1.08M | 0.98M | ||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||
| Capital Expenditures | 0.01M | 0.01M | 0.04M | -0.00M | 0.00M | 0.01M | ||||||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 2.50M | 20.90M | 7.70M | 17.03M | 14.10M | 9.00M | 27.33M | 9.50M | 18.70M | 13.70M | 10.10M | 5.70M | 1.10M | |||||||||||||||||||||
| Cash from Investing Activities | -33.92M | -21.14M | 4.93M | -4.47M | 9.59M | -3.33M | 3.31M | 4.38M | 5.11M | 4.35M | 0.36M | 13.52M | 7.21M | 4.20M | 5.70M | 1.10M | -0.00M | -0.01M | ||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||
| Other financing activities | 16.37M | 88.61M | 1.04M | -0.01M | 0.23M | |||||||||||||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||||||
| Long-Term Debt Repayments | 1.58M | 1.63M | 1.63M | 1.63M | 1.63M | 2.25M | 14.74M | |||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.01M | 0.26M | 1.03M | 0.20M | 0.20M | 0.86M | 0.86M | 0.18M | 0.00M | |||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 0.23M | 0.20M | 0.01M | 0.59M | 7.22M | 0.17M | 5.43M | 13.88M | 6.36M | 0.96M | 5.42M | |||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 15.13M | 86.98M | -0.59M | -1.63M | -1.63M | -2.25M | 0.43M | 0.23M | 0.20M | 0.01M | 0.59M | 7.22M | 0.17M | 5.43M | 13.88M | -8.39M | 5.12M | 5.43M | ||||||||||||||||
| Exchange Rate Effect | 0.02M | -0.01M | 0.00M | -0.01M | 0.02M | -0.02M | -0.03M | -0.03M | 0.03M | -0.01M | -0.01M | -0.02M | -0.01M | -0.03M | -0.02M | -0.03M | -0.00M | -0.02M | 0.01M | -0.00M | ||||||||||||||
| Change in Cash | 6.12M | 51.92M | -30.07M | -0.62M | -8.54M | 3.92M | -22.15M | 11.28M | 0.57M | -4.26M | -3.10M | -8.92M | 1.25M | 1.32M | -2.41M | 8.43M | 10.72M | -11.47M | 0.37M | -2.03M | ||||||||||||||
| Free Cash Flow | -9.03M | -1.13M | -8.34M | -3.91M | -2.47M | -3.40M | -6.26M | -4.55M | -4.31M | -9.59M | -7.63M | -9.26M | -12.84M | -13.08M | -6.76M | -2.67M | -4.26M | -3.06M | -4.75M | -7.46M | ||||||||||||||
| Net Cash Flow | 6.10M | 51.93M | -30.08M | -0.61M | -8.55M | 3.94M | -9.59M | -1.23M | 0.55M | -4.25M | -3.08M | -8.89M | 1.27M | 1.34M | -2.40M | 8.46M | 10.72M | -11.45M | 0.37M | -2.03M |